Osteoarthritis Trials in Duncansville, United States
Conditions / Osteoarthritis / Duncansville, United States
Research into Osteoarthritis spans multiple therapeutic approaches and trial phases.
58 total trials for this combination
Showing top 10 of 58 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01094262 | A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis | TERMINATED | PHASE2 |
| NCT00973141 | A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain | TERMINATED | PHASE2 |
| NCT01089725 | Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study | TERMINATED | PHASE3 |
| NCT00662610 | A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure | COMPLETED | PHASE1 |
| NCT02336685 | Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001 | COMPLETED | PHASE3 |
| NCT00597818 | Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury | COMPLETED | PHASE2 |
| NCT00565812 | A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee | COMPLETED | PHASE2 |
| NCT00809783 | Extension Study Of Tanezumab In Osteoarthritis | TERMINATED | PHASE3 |
| NCT00487435 | An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain | COMPLETED | PHASE3 |
| NCT00373685 | GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) | COMPLETED | PHASE4 |